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ABSTRACT
Background and the purpose of the study: Layer-by-layer (LbL) deposition of polyelectrolytes 
(PEs) has received a great attention in the area of drug delivery due to its simplicity and versatility. 
This research was aimed to develop multilayered microcapsules through LbL deposition of 
chitosan (CHI) and sodium alginate (NaALG) and utilize them as vehicle for controlled delivery 
of isoniazid (INH). 
Methods: CaCO3 particles, prepared by colloidal crystallization of CaCl2 and Na2CO3 
solutions, were used as micro-templates for LbL deposition of CHI and NaALG. Subsequent 
to the deposition, templates were decomposed to obtain hollow microcapsules. Prepared 
microcapsules were subjected to physicochemical evaluations, drug release and stability 
studies. 
Results and major conclusion: Though CaCO3 particles possessed a rough and irregular 
surface, prepared hollow microcapsules were spherical in shape, having smooth surface and 
regular thickness. Following deposition of each layer, alternating values of zeta potential 
were observed, indicating the formation of multilayered films. Microcapsules with 5 bilayers, 
i.e. (CHI/NaALG)5 provided 39% entrapment efficiency and exhibited a controlled release 
behavior, lasting up to 24 hrs. An improvement in drug release rate and stability profile of 
the formulation was observed by increasing the number of deposition steps and performing 
the crosslinking of polyelectrolytes. This study showed that the prepared formulation could 
promisingly be utilized as controlled delivery vehicle for INH.
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INTRODUCTION
Past few decades have witnessed an upsurge in the 
microencapsulation of biomolecules using layer-by-
layer (LbL) deposition. The technique, based on the 
electrostatic interaction between oppositely charged 
polyelectrolytes (PEs), has increasingly received a 
great recognition in the area of drug delivery due 
to its reproducibility, simplicity, versatility, lack of 
requirement of organic solvents and less polymer 
consumption (1-4). By this technique, polyanions 
and polycations are repeatedly allowed to adsorb on 
to the surface of a microtemplate, creating alternating 
regions of opposite charges and subsequent to the 
dissolution of template, hollow polyelectrolyte 
microcapsules (PEMs) are resulted. The multilayer 
film assembly is uniform and continuous, possesses 
a defined composition and reproducible thickness. 
They can deliver a high drug payload and improve 
the pharmacokinetic profile of loaded drug (4). 
The present research was aimed to develop 
multilayered microcapsules based on two ionic 
PEs, chitosan (CHI) and sodium alginate (NaALG). 
They were selected due to their lower cost, 
biocompatibility and versatility of pharmaceutical 
applications. Calcium carbonate (CaCO3) 
microparticles, prepared by colloidal crystallization 
(5), were used as sacrificial micro-templates. Clean 
hollow microcapsules (NaALG/CHI)n, containing no 
residual core, with a narrow size distribution, could 
be achieved with them (2). Microcapsules were 
finally  utilized  as  controlled  release  microcarriers 
of isoniazid (INH), a first line anti-tubercular drug 
which is used for the treatment of all forms of 
tuberculosis. 
MATERIAL AND METHODS
 
Material
Isoniazid (INH) was received as a gift sample 
from Macleod Pharmaceuticals, (Mumbai, India).
Chitosan (CHI) was kindly gifted by Biologicals 
E. Ltd., (Hyderabad, India) and sodium alginate 
(NaALG) was purchased from Central Drug House, 
(New Delhi, India). Fluorescein sodium (FS) was 
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purchased from Hi Media, Mumbai. Other solvents 
and chemicals were procured from manufacturers 
and used as received.
Methods
Formulation of multilayered polyelectrolyte 
microcapsules 
Calcium carbonate microtemplates were prepared 
by colloidal crystallization induced by mixing equal 
volumes of calcium chloride (CaCl2) and sodium 
carbonate (Na2CO3) solutions (5). Solutions of CHI 
and NaALG (1 mg/ml each), prepared in 1% acetic 
acid and triple distilled water (TDW), respectively, 
and filtered through a 0.2 µm membrane syringe 
filter prior to use. Suspension (5% w/v) of the prepared 
CaCO3 particles in 0.5M NaCl was subjected to LbL 
deposition of PEs. Layer deposition was started with 
NaALG and pH was adjusted at each deposition step 
(6,7). The mixture was incubated for 15 min at room 
temperature with gentle stirring. Non-adsorbed PE 
at each deposition was removed by two washings in 
TDW. Subsequent deposition cycles were performed 
in the identical way until desired numbers of PE 
bilayers were achieved. Hollow microcapsules were 
obtained by dissolving the core in 0.1M citric acid 
solution (pH 5.4) (4). Microcapsules were further 
washed with water, centrifuged to remove citric 
acid and finally re-dispersed in TDW. The pH of 
each formulation batch at the time of storage was 
7.0 (±0.2).
Microscopic characterizations
Scanning electron microscopic analysis (SEM) 
of gold sputtered samples was performed at 
an operation voltage of 10 kV (Philips XL-20, 
Holland). Transmission electron microscopic (TEM) 
images were acquired after performing negative 
staining of samples with 1% phospho tungstic acid 
solution (Technai G2, Netherlands). For confocal 
laser scanning microscopic (CLSM) studies, equal 
amounts of microcapsule suspension and an aqueous 
solution of fluorescein sodium (FS; 0.1 mg/ml) were 
mixed one hour before imaging and scanning was 
performed with a 20x Plan Aprochromat objective. 
Images were taken at an excitation wavelength of 488 
nm and band pass of 505-550 nm (Zeiss 510 META, 
Germany). Images were stored and visualized as 
JPEG image format.
Zeta potential measurements
Layer deposition was studied as a function of 
change in zeta potential of the core particles 
(DelsaTM Nano, USA). Suspension was centrifuged 
(2000 rpm/2 min), 100 µl supernatant was collected 
and diluted up to 2 ml with HPLC grade water (8). 
It was placed into the electrophoretic cell, where a 
potential of ±150 mV was applied. The mobility, µ 
was converted to the ζ-potential by Smoluchowski 
relation.
 Entrapment of drug into the prepared PEMs
Microcapsule suspension was centrifuged at 5000 
rpm for 5 min and the supernatant was removed. 
Microcapsule pellet was then dispersed in INH 
solution (2 mg/ml) at room temperature which 
resulted into spontaneous entrapment of drug into 
the formulation. After being incubated for 2 hrs, the 
mixture was centrifuged (2000 rpm/2 min) and INH-
loaded microcapsules were washed twice with water. 
Cross-linking of the formulation was performed by 
overnight treatment with glutaraldehyde. Entrapment 
efficiency (EE) was estimated through the difference 
between theoretical amount (Mt) and the amount 
obtained in the supernatants during washing process 
(Ml) (9). 
%EE = [(Mt – Ml)/Mt] × 100
In vitro drug release studies
In vitro drug release studies of the formulations were 
performed using egg shell membrane. The latter was 
obtained from fresh chicken egg and prepared as 
per the method described by Philip et al. (10). The 
membrane, containing 2 ml of formulation, was 
assembled as a bag and immersed into 10 ml of 
release media, maintained at 37±0.5°C and stirred at 
100 rpm (Decibel Instruments, India). Two different 
media were used: acidic buffer of pH 1.4 (simulated 
gastric fluid without enzyme for 2 hrs) and phosphate 
buffer  of  pH  6.8  (simulated  intestinal  fluid  for 
the rest of the study period). Samples (1 ml) were 
withdrawn at pre-determined time intervals, replaced 
with equal volume of pre-warmed (37±0.5°C) fresh 
medium, filtered through 0.45 µm membrane filter 
and analyzed spectrophotometrically at 262 nm for 
drug content (Shimandzu 7800, Japan). 
Accelerated stability studies
Batches F2 and F3 were stored for 3 months in 
ICH certified stability chamber (NSW-175, India), 
maintained at 40±2°C and 75±5%RH (11). Their 
release characteristics, drug content, size and 
integrity of shape were studied.
RESULTS AND DISCUSSION 
SEM images showed three populations, which 
differed with respect to their surface characteristics 
(Figs. 1a-c). Bare CaCO3 particles presented a 
rough, granular and irregular outline and porous 
structure (Fig. 1a), which could be due to inefficient 
stirring during their precipitation. Surface roughness 
of the template particles, was also desirable as it 
would help adsorption of deposited PEs to form a 
more stable multilayer shell (12). On the contrary, 
hollow (NaALG/CHI)5 microcapsules templated 
upon these particles were almost spherical. Their 
diameters typically ranged between 1 to 5 μm and 
exhibited entirely different surface profile (Fig. 1b), 
which could be explained as follows. Existence of Tiwari et al / DARU 2011 19 (1) 41-46 43
surface charge resulted into inter-digitation among 
the neighboring PE chains. Assuming that excess of 
PEs were removed during washing, matching ratio 
of CHI and NaALG led to creation of a stable film. 
Further, in the process of minimizing free surface 
energy, the overall composite structure oriented into 
a well formed spherical shape and thus, provided an 
even coverage to the template surface (13). However, 
upon drying, microcapsules collapsed, leading to 
creation of various indentations upon the surface 
(Fig. 1c). Also, some microcapsules deformed 
during drying which could be due to the sudden loss 
of water from their matrixes (14).
Alternating zeta potentials were observed up to 
5 pair of deposited layers (Fig. 2), which were 
consistent to the literature reports (15). When 
NaALG formed the outermost layer, the ζ- value 
was negative (-20.53 to 25.17 mV). However, it was 
reversed to a positive value (ranging from 21.38 
mV to 37.24 mV) when CHI layer was adsorbed. 
A significant decrease in the absolute value of zeta 
potential was observed after deposition of two 
initial bilayers; which remained constant thereafter. 
This could be attributed to the nature and density of 
residual charges borne by the respective PE chains 
(16). Thus, regular and stable charge reversal of 
ζ-  value proved that deposition of NaALG/CHI 
multilayers onto CaCO3 microparticles was driven 
by the electrostatic interactions (17) and volume 
fractions of both PEs were proportionate.
Batches F1 (NaALG/CHI)2 (subscript indicates the 
number of deposition cycles), F2 (NaALG/CHI)5, 
F3 (cross-linked NaALG/CHI)5 provided EE of 
34.63±1.31%, 39.24±1.9% and 47.19±1.04%, 
respectively. Difference in EE for each pair of 
formulations  was  significant  (one  way ANOVA, 
P<0.05). Among  others,  high  aqueous  solubility 
of INH could be a primary factor responsible for 
its lower EE. Additional studies were conducted 
upon supernatants to study the effect of washing 
upon EE of the formulations. It was observed that 
between  first  and  second  washing  step,  batches 
F1 and F2 suffered a drug loss of 7.1% and 
3.9%, respectively. However, this effect remained 
insignificant  in  the  subsequent  washing  steps. 
Batch F3 showed a drastic reduction in drug loss 
(1.2%). Crosslinking of PEs might have resulted 
into closing of pores and suppressed the drug loss 
which could presumably have otherwise occurred 
during washing of microcapsules. 
In vitro drug release studies
The release process of INH from the different PEMs 
in buffer systems of pH of 1.2 and 6.8 was studied as 
a function of time (Fig. 3). At the end of 24 hrs, more 
than 95% cumulative release was observed for F1 
and F2; though it differed significantly at different 
time points. The pattern of drug release from the 
formulations could be explained on the basis of 
diffusion and erosion characteristics of the composite 
membrane. Batch F1 released more than 30% drug 
during first 30 min. High aqueous solubility of INH 
would have helped its free diffusion across the 
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Figure 1. Scanning electron microscopic image of: a) prepared 
CaCO3 particles (scale bar 30 µm), b) (CHI/NaALG)5 PEMs (scale 
bar 30 µm) and c) dried (CHI/NaALG)5 PEMs (scale bar 5 µm).Multilayered membrane-controlled microcapsules 44
(NaALG/CHI)2 membrane and thereby, providing 
burst effect. However, release rate was significantly 
improved by increasing the number of bilayers and 
performing cross-linking of PEs. Formulation F2 
showed a sustained release behavior up to 24 hrs, 
which was well in agreement with the findings of Li 
et al. (14). In the case of formulation F3, only 84% 
of the total drug was released in 24 hrs. It differed 
significantly  from  F1  and  F2  (one  way ANOVA; 
P<0.05) which could be due to the adsorption of 
remaining drug within the cross-linked PE complex. 
To understand the mechanism of drug release, in 
vitro  release  data  were  fitted  to  Peppas  equation 
(11,18). The value of n for all the three formulations 
was found to be close to 0.7, which suggested that 
drug release occurred by both, Fickian diffusion and 
erosion. Further, TEM image of the formulation (F2), 
acquired after in vitro dissolution study, exhibited 
a distinct black shadow in the microcapsule center 
(inset b of Fig. 3). It signified that rather than being 
simply adhered onto the wall, drug was localized 
within the microcapsule interior and that the matrix 
was depleted to a greater extent than PE composite 
membrane. CLSM image also supplemented this 
observation (Fig. 3B). It demonstrated an alteration 
in the shape of microcapsules from spherical to 
irregularly shaped and broken micro-structures. The 
results were suggestive that core of microcapsules 
dissolved and eroded upon being subjected to in 
vitro dissolution.
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Figure 2. Change of zeta potential as a function of layer number during LbL adsorption.
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Figure 3. A) In vitro drug release of PEMs as a function of time: F1-un-crosslinked (CHI/NaALG)2, F2-un-crosslinked (CHI/NaALG)5, 
and F3-crosslinked (CHI/NaALG)5; B) confocal microscopic image of F2 after in vitro dissolution study.
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Accelerated stability studies
As it is revealed from TEM image, batch 
F2 exhibited considerable aggregation upon 
accelerated storage conditions (Fig. 4a). Besides a 
significant increase in the bulk pH of microcapsule 
suspension was observed. Deposition of PEs 
was performed within the pH range of 3.5 to 6. 
Formulation,  however,  was  finally  dispersed  and 
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provided a hydrostatic immersion condition during 
storage, this change in microenvironment pH of 
microcapsules could be expected to influence the 
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pH promoted the dissolution of NaALG containing 
carboxylate groups and consequently, overall 
charge distribution of PE complex was destabilized 
(19). As a result, there was an increased propensity 
of physical entanglement among the neighboring 
microcapsules. Besides, hydrogen bonding and 
other  non  specific  interactive  forces  would  also 
have  contributed  significantly  to  the  aggregation 
and clustering. Batch F3, on the other hand, did 
not show any noticeable change either in release 
behavior or morphological characters (Fig. 4b). 
Their pH also remained unchanged. Stable ionic 
crosslinking of amino group of CHI with carboxylic 
acid group of NaALG restrained the swelling of 
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under physiological pH conditions could open up a 
strong possibility of avoiding the use of stabilizer, 
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CONCLUSION
This research demonstrated a successful formulation 
of multilayered microcapsules using LbL technique. 
The prepared microcapsules possessed defined size 
and morphology. Composite membrane constituted 
of biocompatible polyelectrolytes conferred them 
ability to carry a high payload of drug and release it 
in a controlled manner for a period of 24 hrs. Drug 
release rate and stability profile of the formulation 
could be improved by increasing the number of 
deposition steps and performing the cross-linking 
of PEs. Therefore, it could promisingly be utilized 
as a vehicle for controlled and efficacious delivery 
of  isoniazid.  Anchoring  membrane  specific 
components  with  PEs  to  achieve  site  specific 
targeting of the carrier system is the future plan of 
this study. 
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